Cargando…

DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival

Breast cancer patients with Luminal A disease generally have a good prognosis, but among this patient group are patients with good prognosis that are currently overtreated with adjuvant chemotherapy, and also patients that have a bad prognosis and should be given more aggressive treatment. There is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fleischer, Thomas, Klajic, Jovana, Aure, Miriam Ragle, Louhimo, Riku, Pladsen, Arne V., Ottestad, Lars, Touleimat, Nizar, Laakso, Marko, Halvorsen, Ann Rita, Alnæs, Grethe I. Grenaker, Riis, Margit L.H., Helland, Åslaug, Hautaniemi, Sampsa, Lønning, Per Eystein, Naume, Bjørn, Børresen-Dale, Anne-Lise, Tost, Jörg, Kristensen, Vessela N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352035/ https://www.ncbi.nlm.nih.gov/pubmed/27911866 http://dx.doi.org/10.18632/oncotarget.13718

Ejemplares similares

Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumors
por: Aure, Miriam Ragle, et al.
Publicado: (2013)

Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis
por: Fleischer, Thomas, et al.
Publicado: (2014)

Differential DNA methylation analysis of breast cancer reveals the impact of immune signaling in radiation therapy
por: Halvorsen, Ann Rita, et al.
Publicado: (2014)

Identification of sample-specific regulations using integrative network level analysis
por: Liu, Chengyu, et al.
Publicado: (2015)

Data integration to prioritize drugs using genomics and curated data
por: Louhimo, Riku, et al.
Publicado: (2016)

Heterogeneous DNA Methylation Patterns in the GSTP1 Promoter Lead to Discordant Results between Assay Technologies and Impede Its Implementation as Epigenetic Biomarkers in Breast Cancer
por: Grenaker Alnaes, Grethe I., et al.
Publicado: (2015)

Language-Agnostic Reproducible Data Analysis Using Literate Programming
por: Vassilev, Boris, et al.
Publicado: (2016)

Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors
por: Klajic, Jovana, et al.
Publicado: (2013)

Identification of microRNAs involved in pathways which characterize the expression subtypes of NSCLC
por: Halvorsen, Ann Rita, et al.
Publicado: (2019)

Multilocus analysis of SNP and metabolic data within a given pathway
por: Kristensen, Vessela N, et al.
Publicado: (2006)

Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma
por: Bjørklund, Sunniva Stordal, et al.
Publicado: (2017)

Expression of an estrogen-regulated variant transcript of the peroxisomal branched chain fatty acid oxidase ACOX2 in breast carcinomas
por: Bjørklund, Sunniva Stordal, et al.
Publicado: (2015)

Genes harbouring susceptibility SNPs are differentially expressed in the breast cancer subtypes
por: Nordgard, Silje H, et al.
Publicado: (2007)

Identification of genetic markers with synergistic survival effect in cancer
por: Louhimo, Riku, et al.
Publicado: (2013)

Evaluation of MetriGenix custom 4D™ arrays applied for detection of breast cancer subtypes
por: Muggerud, Aslaug Aamodt, et al.
Publicado: (2006)

DNA methylation and gene expression patterns in breast cancer progression from in situ carcinoma to invasive carcinoma
por: Fleischer, Thomas, et al.
Publicado: (2013)

Genetic polymorphisms in the 5' flanking region of glutathione S-transferase P1 affect promoter methylation
por: Rønneberg, JA, et al.
Publicado: (2005)

Identifying In-Trans Process Associated Genes in Breast Cancer by Integrated Analysis of Copy Number and Expression Data
por: Aure, Miriam Ragle, et al.
Publicado: (2013)

Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancer
por: Aure, Miriam Ragle, et al.
Publicado: (2021)

Genome‐wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosis
por: Bjaanæs, Maria Moksnes, et al.
Publicado: (2015)

Fast Gene Ontology based clustering for microarray experiments
por: Ovaska, Kristian, et al.
Publicado: (2008)

DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response
por: Dejeux, Emelyne, et al.
Publicado: (2010)

Identification of several potential chromatin binding sites of HOXB7 and its downstream target genes in breast cancer
por: Heinonen, Henna, et al.
Publicado: (2015)

Serum estradiol levels associated with specific gene expression patterns in normal breast tissue and in breast carcinomas
por: Haakensen, Vilde D, et al.
Publicado: (2011)

Data-driven analysis of immune infiltrate in a large cohort of breast cancer and its association with disease progression, ER activity, and genomic complexity
por: Dannenfelser, Ruth, et al.
Publicado: (2017)

Cis-regulatory mutations associate with transcriptional and post-transcriptional deregulation of gene regulatory programs in cancers
por: Castro-Mondragon, Jaime A, et al.
Publicado: (2022)

miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer
por: Lindholm, Evita Maria, et al.
Publicado: (2019)

Gefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical Trial
por: Engebraaten, Olav, et al.
Publicado: (2012)

Chromosome-wide pharmacogenetics: localisation and linkage disequilibrium of genes coding for ROS metabolism and signalling
por: Edvardsen, H, et al.
Publicado: (2005)

Large-scale data integration framework provides a comprehensive view on glioblastoma multiforme
por: Ovaska, Kristian, et al.
Publicado: (2010)

Let-7 microRNA controls invasion-promoting lysosomal changes via the oncogenic transcription factor myeloid zinc finger-1
por: Tvingsholm, Siri Amanda, et al.
Publicado: (2018)

miR-101-5p Acts as a Tumor Suppressor in HER2-Positive Breast Cancer Cells and Improves Targeted Therapy
por: Normann, Lisa Svartdal, et al.
Publicado: (2022)

Epigenetic alterations at distal enhancers are linked to proliferation in human breast cancer
por: Ankill, Jørgen, et al.
Publicado: (2022)

Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients
por: Helland, Thomas, et al.
Publicado: (2017)

GFRA3 promoter methylation may be associated with decreased postoperative survival in gastric cancer
por: Eftang, Lars Lohne, et al.
Publicado: (2016)

Novel Mad2-targeting miR-493-3p controls mitotic fidelity and cancer cells’ sensitivity to paclitaxel
por: Tambe, Mahesh, et al.
Publicado: (2016)

Deregulation of COMMD1 Is Associated with Poor Prognosis in Diffuse Large B-cell Lymphoma
por: Taskinen, Minna, et al.
Publicado: (2014)

Subtype and cell type specific expression of lncRNAs provide insight into breast cancer
por: Bjørklund, Sunniva Stordal, et al.
Publicado: (2022)

NSCLC depend upon YAP expression and nuclear localization after acquiring resistance to EGFR inhibitors
por: McGowan, Marc, et al.
Publicado: (2017)

Long Non-Coding RNAs Differentially Expressed between Normal versus Primary Breast Tumor Tissues Disclose Converse Changes to Breast Cancer-Related Protein-Coding Genes
por: Reiche, Kristin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3dmpcnik2s1bok032s9vogeefh